欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0406/007
药品名称Diovan
活性成分
    • valsartan 3.0 mg/ml
剂型Oral solution
上市许可持有人Novartis Sverige AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Hungary (HU)
    • Austria (AT)
      Diovan 3 mg/ml Lösung zum Einnehmen
    • Belgium (BE)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Estonia (EE)
      DIOVAN
    • Finland (FI)
    • France (FR)
    • Germany (DE)
    • Greece (GR)
    • Ireland (IE)
    • Italy (IT)
    • Lithuania (LT)
      Diovan 3mg/ml geriamasis tirpalas
    • Luxembourg (LU)
    • Latvia (LV)
      Diovan 3 mg/ml šķīdums iekšķīgai lietošanai
    • Malta (MT)
    • Netherlands (NL)
    • Norway (NO)
    • Poland (PL)
    • Portugal (PT)
    • Romania (RO)
      DIOVAN 3 mg/ml soluţie orală
    • Slovenia (SI)
    • Slovakia (SK)
    • Spain (ES)
    • Denmark (DK)
    • Iceland (IS)
许可日期2010/04/27
最近更新日期2024/02/29
药物ATC编码
    • C09CA03 valsartan
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase